MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 165 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $16,000 | +33.3% | 656 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $12,000 | +9.1% | 656 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $11,000 | +37.5% | 656 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $8,000 | -20.0% | 656 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $10,000 | 0.0% | 656 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $10,000 | +25.0% | 656 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $8,000 | +14.3% | 656 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $7,000 | 0.0% | 656 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $7,000 | +16.7% | 656 | +4.8% | 0.00% | 0.0% |
Q2 2016 | $6,000 | +200.0% | 626 | +154.5% | 0.00% | – |
Q1 2016 | $2,000 | -33.3% | 246 | 0.0% | 0.00% | -100.0% |
Q4 2015 | $3,000 | -50.0% | 246 | -36.8% | 0.00% | 0.0% |
Q3 2015 | $6,000 | -25.0% | 389 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $8,000 | +60.0% | 389 | +4.9% | 0.00% | 0.0% |
Q1 2015 | $5,000 | +400.0% | 371 | +159.4% | 0.00% | – |
Q4 2014 | $1,000 | -75.0% | 143 | -67.1% | 0.00% | -100.0% |
Q3 2014 | $4,000 | 0.0% | 434 | +5.9% | 0.00% | 0.0% |
Q2 2014 | $4,000 | 0.0% | 410 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $4,000 | -33.3% | 410 | 0.0% | 0.00% | 0.0% |
Q4 2013 | $6,000 | +50.0% | 410 | +48.0% | 0.00% | -66.7% |
Q2 2012 | $4,000 | 0.0% | 277 | 0.0% | 0.00% | 0.0% |
Q1 2012 | $4,000 | – | 277 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |